Ahead of the Cancer Curve: Recent Episodes
Exact Sciences
Hosted by Dr. Rick Baehner, Chief Medical Officer for Precision Oncology at Exact Sciences, Ahead of the Cancer Curve explores the world of cancer diagnostics and its cutting-edge science. Dr. Baehner will interview those that are on the front lines of cancer, and those behind the scenes, driving the life-changing innovations in cancer detection, treatment guidance, and monitoring.
In this episode, Dr. Baehner welcomes Dr. Scott Sellinger, who has over 35 years of experience as a urologist and is currently the President of the Advanced Urology Institute. With his experience, Dr. Sellinger brings his unique insight into the current trends in the management of prostate cancer, the multiple technologies to aid decision-making and localized and advanced disease and what exciting developments are still on the horizon.
In this episode, Dr. Baehner welcomes Dr. Scott Sellinger, who has over 35 years of experience as a urologist and is currently the President of the Advanced Urology Institute. With his experience, Dr. Sellinger brings his unique insight into the current trends in the management of prostate cancer, the multiple technologies to aid decision-making and localized and advanced disease and what exciting developments are still on the horizon.
In this episode, Dr. Baehner welcomes Dr. Paul Limburg, Chief Medical Officer of Screening at Exact Sciences. Dr. Limburg is also a Professor of Medicine in the Mayo Clinic College of Medicine. He has served on several enterprise-wide committees at Mayo Clinic, including the Management Team and the Clinical Practice Committee. With his experience, Dr. Limburg brings his unique insight into the current cancer diagnostics landscape and where he sees it going.
In this episode, Dr. Baehner welcomes Dr. Paul Limburg, Chief Medical Officer of Screening at Exact Sciences. Dr. Limburg is also a Professor of Medicine in the Mayo Clinic College of Medicine. He has served on several enterprise-wide committees at Mayo Clinic, including the Management Team and the Clinical Practice Committee. With his experience, Dr. Limburg brings his unique insight into the current cancer diagnostics landscape and where he sees it going.